Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2015-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the present study, the aim was to compare the efficacy and safety of epidural or intravenous oxycodone in patients undergoing elective gynecological surgery with planned epidural pain treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
NCT05761860
A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)
NCT00580294
A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects
NCT02391571
A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain
NCT01971632
Epidural Methadone in Healthy Volunteers
NCT03525509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxycodone intravenously
Oxycodone 0,1 mg/kg IV
Oxycodone epidurally
Oxycodone 0,1 mg epidurally
Oxycodone epidurally
Oxycodone 0,1 mg/kg epidurally
Oxycodone intravenously
Oxycodone intravenously 0,1mg/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxycodone intravenously
Oxycodone intravenously 0,1mg/kg
Oxycodone epidurally
Oxycodone 0,1 mg epidurally
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent obtained
Exclusion Criteria
* contraindication to the study drug
* contraindication to the lumbar puncture
* Contraindication to oxycodone
* Pregnancy or lactation
* no informed consent
18 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Admescope Ltd
INDUSTRY
Kuopio University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merja Kokki
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merja Kokki, PhD
Role: PRINCIPAL_INVESTIGATOR
Kuopio University Hospital, Kuopio, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kuopio University Hospital
Kuopio, Northern Savonia, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH2014-004313-82
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.